Do analysts prefer AGPU or RVP?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Predictive Oncology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend RVP or LNSR?

LENSAR has a consensus price target of $10.00, suggesting a potential upside of 72.71%. Given LENSAR's stronger consensus rating and higher probable upside, analysts plainly believe LENSAR is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 LENSAR 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts prefer RVP or POCI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Precision Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend RVP or LUNG?

Pulmonx has a consensus price target of $5.58, indicating a potential upside of 321.38%. Given Pulmonx's stronger consensus rating and higher possible upside, analysts clearly believe Pulmonx is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Pulmonx 1 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.43

Do analysts prefer RVP or MDAI?

Spectral AI has a consensus target price of $4.00, suggesting a potential upside of 116.80%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts plainly believe Spectral AI is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Spectral AI 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Retractable Technologies (RVP) Competitors

$0.70 0.00 (-0.53%)

As of 10:33 AM Eastern

Compare

RVP vs. AGPU, LNSR, POCI, LUNG, and MDAI

Should you buy Retractable Technologies stock or one of its competitors? MarketBeat compares Retractable Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Retractable Technologies include Predictive Oncology (AGPU), LENSAR (LNSR), Precision Optics (POCI), Pulmonx (LUNG), and Spectral AI (MDAI). These companies are all part of the "medical equipment" industry.

How does Retractable Technologies compare to Predictive Oncology?

Predictive Oncology (NASDAQ:AGPU) and Retractable Technologies (NYSE:RVP) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Retractable Technologies has a net margin of -41.11% compared to Predictive Oncology's net margin of -470,383.31%. Retractable Technologies' return on equity of -17.15% beat Predictive Oncology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Predictive Oncology	-470,383.31%	-7,363.67%	-626.32%
Retractable Technologies	-41.11%	-17.15%	-9.33%

Retractable Technologies has higher revenue and earnings than Predictive Oncology. Retractable Technologies is trading at a lower price-to-earnings ratio than Predictive Oncology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Predictive Oncology	$120K	637.57	-$233.10M	-$8.18	N/A
Retractable Technologies	$37.15M	0.56	-$7.01M	-$0.21	N/A

In the previous week, Predictive Oncology had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for Predictive Oncology and 0 mentions for Retractable Technologies. Predictive Oncology's average media sentiment score of 0.93 beat Retractable Technologies' score of 0.00 indicating that Predictive Oncology is being referred to more favorably in the media.

Company	Overall Sentiment
Predictive Oncology	Positive
Retractable Technologies	Neutral

Predictive Oncology has a beta of 3.47, indicating that its stock price is 247% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market.

9.0% of Predictive Oncology shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 1.2% of Predictive Oncology shares are held by company insiders. Comparatively, 59.5% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Predictive Oncology and Retractable Technologies tied by winning 7 of the 14 factors compared between the two stocks.

How does Retractable Technologies compare to LENSAR?

Retractable Technologies (NYSE:RVP) and LENSAR (NASDAQ:LNSR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

Retractable Technologies has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.56	-$7.01M	-$0.21	N/A
LENSAR	$58.44M	1.20	-$34.28M	-$0.58	N/A

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 40.2% of LENSAR shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by insiders. Comparatively, 66.0% of LENSAR shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Retractable Technologies has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, LENSAR has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

LENSAR has a net margin of 50.94% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat LENSAR's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
LENSAR	50.94%	-183.19%	42.26%

In the previous week, LENSAR had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for LENSAR and 0 mentions for Retractable Technologies. LENSAR's average media sentiment score of 0.63 beat Retractable Technologies' score of 0.00 indicating that LENSAR is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Neutral
LENSAR	Positive

LENSAR has a consensus price target of $10.00, suggesting a potential upside of 72.71%. Given LENSAR's stronger consensus rating and higher probable upside, analysts plainly believe LENSAR is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
LENSAR	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

LENSAR beats Retractable Technologies on 11 of the 16 factors compared between the two stocks.

How does Retractable Technologies compare to Precision Optics?

Retractable Technologies (NYSE:RVP) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by company insiders. Comparatively, 14.4% of Precision Optics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Precision Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Precision Optics has a net margin of -17.03% compared to Retractable Technologies' net margin of -41.11%. Retractable Technologies' return on equity of -17.15% beat Precision Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Precision Optics	-17.03%	-37.47%	-19.96%

In the previous week, Precision Optics had 2 more articles in the media than Retractable Technologies. MarketBeat recorded 2 mentions for Precision Optics and 0 mentions for Retractable Technologies. Precision Optics' average media sentiment score of 0.94 beat Retractable Technologies' score of 0.00 indicating that Precision Optics is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Neutral
Precision Optics	Positive

Retractable Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market. Comparatively, Precision Optics has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market.

Precision Optics has lower revenue, but higher earnings than Retractable Technologies. Precision Optics is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.56	-$7.01M	-$0.21	N/A
Precision Optics	$19.09M	3.44	-$5.78M	-$0.63	N/A

Summary

Retractable Technologies and Precision Optics tied by winning 7 of the 14 factors compared between the two stocks.

How does Retractable Technologies compare to Pulmonx?

Retractable Technologies (NYSE:RVP) and Pulmonx (NASDAQ:LUNG) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk.

Retractable Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market. Comparatively, Pulmonx has a beta of 0.28, suggesting that its share price is 72% less volatile than the broader market.

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 91.0% of Pulmonx shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by insiders. Comparatively, 6.8% of Pulmonx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Pulmonx had 1 more articles in the media than Retractable Technologies. MarketBeat recorded 1 mentions for Pulmonx and 0 mentions for Retractable Technologies. Pulmonx's average media sentiment score of 1.87 beat Retractable Technologies' score of 0.00 indicating that Pulmonx is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Neutral
Pulmonx	Very Positive

Retractable Technologies has a net margin of -41.11% compared to Pulmonx's net margin of -60.09%. Retractable Technologies' return on equity of -17.15% beat Pulmonx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Pulmonx	-60.09%	-92.94%	-39.80%

Retractable Technologies has higher earnings, but lower revenue than Pulmonx. Retractable Technologies is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.56	-$7.01M	-$0.21	N/A
Pulmonx	$90.50M	0.62	-$54M	-$1.30	N/A

Pulmonx has a consensus price target of $5.58, indicating a potential upside of 321.38%. Given Pulmonx's stronger consensus rating and higher possible upside, analysts clearly believe Pulmonx is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Pulmonx	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Summary

Pulmonx beats Retractable Technologies on 9 of the 16 factors compared between the two stocks.

How does Retractable Technologies compare to Spectral AI?

Retractable Technologies (NYSE:RVP) and Spectral AI (NASDAQ:MDAI) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Retractable Technologies has higher revenue and earnings than Spectral AI. Spectral AI is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$37.15M	0.56	-$7.01M	-$0.21	N/A
Spectral AI	$19.65M	2.99	-$7.57M	-$0.53	N/A

In the previous week, Spectral AI had 4 more articles in the media than Retractable Technologies. MarketBeat recorded 4 mentions for Spectral AI and 0 mentions for Retractable Technologies. Spectral AI's average media sentiment score of 0.60 beat Retractable Technologies' score of 0.00 indicating that Spectral AI is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Neutral
Spectral AI	Positive

Retractable Technologies has a net margin of -41.11% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Spectral AI	-85.58%	N/A	-72.97%

Spectral AI has a consensus target price of $4.00, suggesting a potential upside of 116.80%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts plainly believe Spectral AI is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 67.1% of Spectral AI shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by company insiders. Comparatively, 13.7% of Spectral AI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Retractable Technologies has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market. Comparatively, Spectral AI has a beta of 1.15, indicating that its stock price is 15% more volatile than the broader market.

Summary

Retractable Technologies and Spectral AI tied by winning 8 of the 16 factors compared between the two stocks.

Get Retractable Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RVP vs. The Competition

Export

Metric	Retractable Technologies	Surgical & medical instruments Industry	Medical Sector	NYSE Exchange
Market Cap	$20.84M	$40.21M	$6.49B	$23.46B
Dividend Yield	N/A	1.08%	2.67%	4.05%
P/E Ratio	-1.29	17.96	24.05	31.85
Price / Sales	0.56	28.18	542.61	111.54
Price / Cash	48.25	18.86	27.48	18.65
Price / Book	0.21	12.30	10.69	4.75
Net Income	-$7.01M	-$16.77M	$3.57B	$1.08B
7 Day Performance	1.90%	2.89%	1.56%	3.09%
1 Month Performance	8.75%	-3.33%	2.49%	4.46%
1 Year Performance	6.91%	-8.31%	26.51%	25.48%

Retractable Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RVP Retractable Technologies	N/A	$0.70 -0.5%	N/A	+7.5%	$20.84M	$37.15M	N/A	240
AGPU Predictive Oncology	0.7754 of 5 stars	$6.68 -1.3%	N/A	N/A	$69.47M	$120K	N/A	30	Analyst Upgrade
LNSR LENSAR	2.4472 of 5 stars	$5.68 -0.2%	$10.00 +76.1%	-53.4%	$68.73M	$58.44M	N/A	110	Gap Up
POCI Precision Optics	0.3785 of 5 stars	$5.65 -0.5%	N/A	+26.1%	$61.81M	$19.09M	N/A	80	Gap Down
LUNG Pulmonx	2.2027 of 5 stars	$1.43 -6.5%	$5.58 +290.4%	-54.8%	$60.40M	$90.50M	N/A	250	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:RVP) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Retractable Technologies (RVP) Competitors

RVP vs. AGPU, LNSR, POCI, LUNG, and MDAI

How does Retractable Technologies compare to Predictive Oncology?

Summary

How does Retractable Technologies compare to LENSAR?

Summary

How does Retractable Technologies compare to Precision Optics?

Summary

How does Retractable Technologies compare to Pulmonx?

Summary

How does Retractable Technologies compare to Spectral AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RVP vs. The Competition

Retractable Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Retractable Technologies (RVP) Competitors

RVP vs. AGPU, LNSR, POCI, LUNG, and MDAI

How does Retractable Technologies compare to Predictive Oncology?

Do analysts prefer AGPU or RVP?

Is AGPU or RVP more profitable?

Which has better earnings & valuation, AGPU or RVP?

Does the media refer more to AGPU or RVP?

Which has more volatility and risk, AGPU or RVP?

Do insiders and institutionals believe in AGPU or RVP?

Summary

How does Retractable Technologies compare to LENSAR?

Which has stronger earnings and valuation, RVP or LNSR?

Do insiders and institutionals hold more shares of RVP or LNSR?

Which has more volatility & risk, RVP or LNSR?

Is RVP or LNSR more profitable?

Does the media favor RVP or LNSR?

Do analysts recommend RVP or LNSR?

Summary

How does Retractable Technologies compare to Precision Optics?

Do institutionals and insiders believe in RVP or POCI?

Do analysts prefer RVP or POCI?

Is RVP or POCI more profitable?

Does the media prefer RVP or POCI?

Which has more risk and volatility, RVP or POCI?

Which has stronger earnings and valuation, RVP or POCI?

Summary

How does Retractable Technologies compare to Pulmonx?

Which has more volatility & risk, RVP or LUNG?

Do insiders and institutionals believe in RVP or LUNG?

Does the media favor RVP or LUNG?

Is RVP or LUNG more profitable?

Which has higher earnings and valuation, RVP or LUNG?

Do analysts recommend RVP or LUNG?

Summary

How does Retractable Technologies compare to Spectral AI?

Which has better earnings & valuation, RVP or MDAI?

Does the media prefer RVP or MDAI?

Is RVP or MDAI more profitable?

Do analysts prefer RVP or MDAI?

Do insiders and institutionals have more ownership in RVP or MDAI?

Which has more risk & volatility, RVP or MDAI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RVP vs. The Competition

Retractable Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools